Stefan_Ciurea

Haplo-identical Stem Cell Transplant- All tweets are my own.

[Morbific, LLC @morbificLLC]

Come by to chat with us @ the MDACC booth (#2312), sign up for @MDRingApp while you're here!! #AACR16

[Morbific, LLC @morbificLLC]

Which of the following best describes the function of anti-PD-1 antibodies?

Answer the question using @MDRingApp; use invite code: AACR16

[Mehdi Hamadani, MD @MediHumdani]

Feasibilty of 3rd part Haploidentical NK cells prior to alloHCT- #bmtsm @Haplo_Doc https://t.co/v9oaLoyrB3

[Stefan_Ciurea @Haplo_Doc]

Excited for ASBMT's latest issue of BBMT featuring "Proceedings from the 2nd Haplo-SCT Symposium"! Read the article https://t.co/7luNOGCcY5

[Stefan_Ciurea @Haplo_Doc]

Try @MDRingApp "For physicians, by physicians"!!! https://t.co/IqsdaWcQq7

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

.@MDRingApp is a mobile first #MedED app for iOS ( https://t.co/8Tn64VXAHY ) & Android ( https://t.co/YhMKy4N2h7 ) By doctors, for doctors.

[Muzaffar Qazilbash @Transplant_Doc]

The Stem Cell Transplant Daily is out! https://t.co/xAl0D68sLS Stories via @DrMiguelPerales

[Stefan_Ciurea @Haplo_Doc]

"Transforming Healthcare via Twitter: A physician's perspective" by Navneet Majhail 👍🏼 https://t.co/EwWzmSCzya

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Transforming healthcare w/ Twitter: A physician’s perspective by Navneet Majhail [ @BldCancerDoc v @VJHemOnc https://t.co/ulupwJULYP #EBMT16

[Mohamad Mohty @Mohty_EBMT]

The "Walk for Life" a major highlight of #EBMT16 @TheEBMT @Mohty_EBMT @HJeanKhouryMD @DrFadloKhuri

[EBMT @TheEBMT]

#EBMT16 Closing Session: presentation & @npgnews Awards: best clinical poster to D. Miklos & best science poster to D. Niec

[Mohamad Mohty @Mohty_EBMT]

@BldCancerDoc touring sessions for great coverage of #EBMT16

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

#EBMT16 CART #ImmunoOnc #bmtsm Porter - CAR T cells bf, after or instead of allo SCT:

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

#EBMT16 CART #ImmunoOnc #bmtsm Porter - CAR T cells bf, after, or instead of allo SCT: CLL - rationale for novel Rx

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

#EBMT16 CART #ImmunoOnc #bmtsm Porter - CAR T cells bf, after or instead of allo SCT: CD19 summary

[Helen Ong @Lin_ling_88]

$BLCM: copies of slides presented st EBMT (4/5)
https://t.co/q0y1fOqKqY

[EBMT @TheEBMT]

#EBMT16 Social Media Session with @mtmdphd @BldCancerDoc @mvdweijden this morning at 9.00

[Mohamad Mohty @Mohty_EBMT]

@TheEBMT @Mohty_EBMT

[Dan Diamond @ddiamond]

At current pace, health care will become the biggest job sector in America within 3 years.

[Stefan_Ciurea @Haplo_Doc]

Follow @MDRing App for the latest in physician research and education https://t.co/CsnbjzoMaA

[Morbific, LLC @morbificLLC]

@Haplo_Doc what is your preferred choice of alternative donor for allo-HSCT for MAL in CR1?

[Zachariah DeFilipp @DrZackDeFilipp]

Come hear my mentor @ekwaller speak about dendritic cells at #GVHD forum, Tuesday #EBMT16

[Karen Sweiss @KarenSweiss]

Improved graft-versus-host disease-free, RFS associated with bone marrow as the stem cell source in adults https://t.co/Z5L0lpZNOq